Silexion Therapeutics Ltd... (SLXN)
NASDAQ: SLXN
· Real-Time Price · USD
3.75
-0.03 (-0.79%)
At close: Oct 15, 2025, 3:59 PM
3.74
-0.27%
After-hours: Oct 15, 2025, 06:12 PM EDT
Silexion Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | n/a | n/a | n/a | n/a |
Cost of Revenue | 25K | n/a | n/a | n/a |
Gross Profit | -25K | n/a | n/a | n/a |
Operating Income | -12.57M | -4.68M | -3.86M | -943.93K |
Interest Income | 1K | 153K | 114K | 6.37K |
Pretax Income | -16.51M | -5.08M | -3.46M | -755.22K |
Net Income | 16.51M | -4.94M | -3.21M | -755K |
Selling & General & Admin | 6.76M | 928K | 577K | 943.93K |
Research & Development | 5.82M | 3.71M | 3.23M | n/a |
Other Expenses | n/a | 45K | 57K | n/a |
Operating Expenses | 12.57M | 4.68M | 3.86M | 943.93K |
Interest Expense | 52K | 9K | 85K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 12.57M | 4.68M | 3.86M | 943.93K |
Income Tax Expense | 10K | 32K | 24K | n/a |
Shares Outstanding (Basic) | 6.24M | 1.12M | 16.73M | 16.51M |
Shares Outstanding (Diluted) | 6.24M | 1.12M | 16.73M | 16.51M |
EPS (Basic) | -2.64 | -4.42 | 0.03 | -0.05 |
EPS (Diluted) | -2.64 | -4.42 | 0.03 | -0.05 |
EBITDA | -16.43M | -4.64M | -3.8M | -755K |
EBIT | -16.46M | -4.68M | -3.86M | -755K |
Depreciation & Amortization | 25K | 45K | 57K | n/a |
Source: Financial Modeling Prep. Financial Sources.